 | • レポートコード：TPM-NV095 • 出版社/出版日：Transparency Market Research / 2019年8月9日 • レポート形態：英文、PDF、168ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、鼻ポリープ治療の世界市場について調べ、鼻ポリープ治療の世界市場規模、市場動向、市場シェア、市場環境、市場予測、治療種類別（薬理療法（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、および手術（ポリペクトミー、機能的内視鏡下副鼻腔手術（FESS）））分析、エンドユーザー別（病院、外来手術センター、専門クリニック）分析、関連企業情報などをまとめました。 ・鼻ポリープ治療の市場概要 ・鼻ポリープ治療の市場動向 ・鼻ポリープ治療の世界市場規模・予測 ・鼻ポリープ治療市場：治療種類別（薬理療法（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、および手術（ポリペクトミー、機能的内視鏡下副鼻腔手術（FESS））） ・鼻ポリープ治療市場：エンドユーザー別（病院、外来手術センター、専門クリニック） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
A new study on the global nasal polyps treatment market was published by Transparency Market Research (TMR). It presents a wealth of information on the key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the nasal polyps treatment market. TMR’s study offers valuable information about the nasal polyps treatment market, to illustrate how growth will discern during the forecast period of 2019–2027.
Key indicators of market growth, which include value chain as well as supply chain analysis, and Compound Annual Growth Rate (CAGR), are elucidated in TMR’s study in a comprehensive manner. This data can help readers interpret the quantitative growth aspects of the nasal polyps treatment market during the forecast period.
An extensive analysis on leading market players’ business strategies is also featured in TMR’s study on the nasal polyps treatment market. This can help readers understand principal factors to foresee growth in the nasal polyps treatment market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the nasal polyps treatment market, which will guide market players in making apt decisions in the future.
Segmentation of the Nasal Polyps Treatment Market
TMR’s study on the nasal polyps treatment market includes information bifurcated into three sections – by type of treatment, by end user, and by region. Changing industry trends and other crucial market dynamics associated with these sections of the nasal polyps treatment market are discussed in detail.
Key Questions Answered in TMR’s Nasal Polyps Treatment Market Study
What is the scope of growth of nasal polyps treatment companies in the surgical treatment sector?
What will be the Y-o-Y growth of the nasal polyps treatment market between 2019 and 2027?
What is the influence of the changing trends in technologies on the nasal polyps treatment market?
Will North America continue to remain the most profitable regional market for nasal polyps treatment providers?
Which factors will impede the growth of the nasal polyps treatment market during the forecast period?
Which are the leading companies in the global nasal polyps treatment market?
Research Methodology
A unique research methodology is utilized by TMR to conduct comprehensive research on the growth of the nasal polyps treatment market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the production of the nasal polyps treatment market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the nasal polyps treatment market, as a primary resource.
These primary and secondary resources provided exclusive information during the interviews, which serves as a validation from nasal polyps treatment industry leaders. Access to an extensive internal repository and external proprietary databases allows for this report to address specific details and questions about the nasal polyps treatment market with accuracy. The study also uses a top-down approach to assess the numbers for each segment, and a bottom-up approach to counter-validate them. This has helped in making TMR’s estimates on the future prospects of the nasal polyps treatment market more reliable and accurate.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Polyps Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Pipeline Analysis
5.3. Qualitative Assessment on Novel Treatment Options for Nasal Polyps: Biologics & Stents
5.3.1. Key Insights on Biologics (Xolair, Dupixent, Nucala)
6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment
6.1. Introduction & Definition
6.2. Market Value Forecast, by Type of Treatment , 2017–2027
6.2.1. Pharmacological Therapies
6.2.1.1. Corticosteroids
6.2.1.2. Antibiotics
6.2.1.3. Leukotriene Inhibitors
6.2.1.4. Others
6.2.2. Surgeries
6.2.2.1. Polypectomy
6.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
6.3. Market Attractiveness By Type of Treatment
7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Market Value Forecast, by End-user, 2017–2027
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Specialty Clinics
7.3. Market Attractiveness, by End-user
8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region
8.1. Introduction
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Nasal Polyps Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast, by Type of Treatment , 2017–2027
9.2.1. Pharmacological Therapies
9.2.1.1. Corticosteroids
9.2.1.2. Antibiotics
9.2.1.3. Leukotriene Inhibitors
9.2.1.4. Others
9.2.2. Surgeries
9.2.2.1. Polypectomy
9.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Value Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type of Treatment
9.5.2. By End-user
9.5.3. By Country
10. Europe Nasal Polyps Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Type of Treatment , 2017–2027
10.2.1. Pharmacological Therapies
10.2.1.1. Corticosteroids
10.2.1.2. Antibiotics
10.2.1.3. Leukotriene Inhibitors
10.2.1.4. Others
10.2.2. Surgeries
10.2.2.1. Polypectomy
10.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
10.3. Market Value Forecast, by End-user, 2017–2027
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Specialty Clinics
10.4. Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type of Treatment
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Type of Treatment, 2017–2027
11.2.1. Pharmacological Therapies
11.2.1.1. Corticosteroids
11.2.1.2. Antibiotics
11.2.1.3. Leukotriene Inhibitors
11.2.1.4. Others
11.2.2. Surgeries
11.2.2.1. Polypectomy
11.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
11.3. Market Value Forecast, by End-user, 2017–2027
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Specialty Clinics
11.4. Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type of Treatment
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Nasal Polyps Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Type of Treatment, 2017–2027
12.2.1. Pharmacological Therapies
12.2.1.1. Corticosteroids
12.2.1.2. Antibiotics
12.2.1.3. Leukotriene Inhibitors
12.2.1.4. Others
12.2.2. Surgeries
12.2.2.1. Polypectomy
12.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
12.3. Market Value Forecast, by End-user, 2017–2027
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Specialty Clinics
12.4. Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type of Treatment
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Type of Treatment , 2017–2027
13.2.1. Pharmacological Therapies
13.2.1.1. Corticosteroids
13.2.1.2. Antibiotics
13.2.1.3. Leukotriene Inhibitors
13.2.1.4. Others
13.2.2. Surgery
13.2.2.1. Polypectomy
13.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
13.3. Market Value Forecast, by End-user, 2017–2027
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Specialty Clinics
13.4. Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Type of Treatment
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Global Nasal Polyps Treatment Market Position Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. OptiNose US, Inc.
14.3.2. Regeneron Pharmaceuticals, Inc.
14.3.3. Merck & Co., Inc.
14.3.4. Pfizer, Inc.
14.3.5. F. Hoffmann La-Roche, Ltd.
14.3.6. Intersect ENT, Inc.
14.3.7. GlaxoSmithKline plc
14.3.8. Sanofi
14.3.9. Novartis AG
Table 01: Pipeline Analysis: Nasal Polyps
Table 02: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 04: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 05: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 09: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 10: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 11: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 12: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 14: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 15: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 16: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 17: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 19: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 20: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 21: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 22: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 24: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 25: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 26: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 27: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 29: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 30: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 31: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027